Miroslawa K. D.
- Country
- Poland
- Department
- N/A
Research Overview
- A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Background of Methotrexate (MTX) and Who Have an Inadequate Response to MTX (MTX-IR)
- Efficacy and Safety Evaluation of Deucravacitinib in Biologic-Naïve Patients with Active Psoriatic Arthritis: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 15 of 122 partner sites.
Specializations
Rheumatological Conditions
The investigator specializes in treating complex rheumatological disorders, with particular emphasis on rheumatoid arthritis and psoriatic arthritis. Their research encompasses innovative therapeutic approaches for patients with active forms of these conditions.
- Autoimmune Arthritis Management
- Inflammatory Joint Disorders
- Chronic Pain Conditions
Their work extends to treating patients who show inadequate response to conventional therapies.
Immunological Therapeutics
The investigator focuses on advanced immunomodulatory treatments, including novel therapeutic agents such as deucravacitinib and upadacitinib. Their expertise includes evaluating innovative treatment approaches for autoimmune conditions.
- Targeted Immunotherapy
- Biological Response Modifiers
- Disease-Modifying Treatments
Their research encompasses both established and emerging therapeutic options for inflammatory conditions.
Treatment Optimization
The investigator specializes in developing therapeutic strategies for patients with varying response levels to standard treatments. Their work includes evaluation of combination therapies involving methotrexate and advanced biological agents.
- Treatment Response Assessment
- Therapeutic Drug Monitoring
- Long-term Disease Management
Their expertise includes optimizing treatment outcomes for patients with resistant disease forms.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.